---
category: news
title: "CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences"
excerpt: "CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences (\"Reveal\"), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry."
publishedDateTime: 2021-05-11T12:30:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-1030414543"
webUrl: "https://markets.businessinsider.com/news/stocks/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-1030414543"
type: article
quality: 9
heat: 9
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "MuR06kTipD5H+tv0AiUIw6OThP+0yNLX0qCqN4GqxkScX1PAJ98bvdZot/HLdYKyQ4yMvrlBilbUgkuwEpmTimt9WZGXjrZVJeSmRnwXAZVAbgob6IKaf/vgcUmE6bujivtavStPp4qPjeTx/8LCU2rl/oXGdBJgRMp9fyZ6P37Ot51oagdqagtEImdH7w8kCDX59IvFTa1RJyDY1iZ60gG6rzRzxQ4ZDXnWDmaxBTRTq9JTzoyQ8qqKZP0R+aZnLHaGcyVGUI9cGUAgyFuDzCSgQjlnVlQTHxXeibwTXH8M00OCE5rzBkmwd2gnW/JupuQAI/bLy3X6GCkHyOTtyZWDN59ti0ubxKGJ/oaP1s8=;tsobCD6To5rRepMyefJh9A=="
---

